Antimicrobial Resistance Patterns in Patients with Vaginal Discharge: A 2019-2022 Analysis at the National Health Laboratory in Eritrea

Table 4

Antimicrobial sensitivities of vaginal swab in National Health Laboratory (gram-positive species).

		S. aureus ()	Strep. spp. ()	Total, (%) ()	value
Ampicillin	I	0 (0.0)	0 (0.0)	14 (10.1)	0.85
	R	0 (0.0)	4 (80.0)	98 (71.0)
	S	0 (0.0)	1 (20.0)	26 (18.8)
Chloramphenicol	I	2 (7.4)	0 (0.0)	3 (1.8)	0.01
	R	3 (11.1)	5 (50.0)	26 (15.3)
	S	22 (81.5)	5 (50.0)	141 (82.9)
Ciprofloxacin	I	3 (11.1)	2 (40.0)	13 (7.9)	0.001
	R	8 (29.6)	3 (60.0)	29 (17.6)
	S	16 (59.3)	0 (0.0)	123 (74.5)
Trimethoprim-sulfamethoxazole	I	1 (3.7)	0 (0.0)	7 (4.4)	0.22
	R	17 (63.0)	0 (0.0)	78 (48.8)
	S	9 (33.3)	0 (0.0)	75 (46.9)
Gentamicin	I	1 (3.7)	1 (16.7)	23 (13.9)	0.001
	R	8 (29.6)	2 (33.3)	41 (24.7)
	S	18 (66.7)	2 (33.3)	101 (60.8)
Nitrofurantoin	I	0 (0.0)	0 (0.0)	13 (8.1)	0.001
	R	2 (7.4)	0 (0.0)	27 (16.8)
	S	25 (92.6)	0 (0.0)	120 (74.5)
Tetracycline	I	0 (0.0)	0 (0.0)	5 (3.0)	0.33
	R	12 (46.2)	7 (70.0)	88 (52.1)
	S	14 (53.8)	3 (30.0)	76 (45.0)
Clindamycin	I	8 (29.6)	0 (0.0)	8 (25.0)	0.001
	R	0 (0.0)	3 (60.0)	3 (9.4)
	S	19 (70.4)	2 (40.0)	21 (65.6)
Erythromycin	I	7 (25.9)	2 (20.0)	9 (24.3)	0.018
	R	6 (22.2)	7 (70.0)	13 (35.1)
	S	14 (51.9)	1 (10.0)	15 (40.5)
Oxacillin	I	3 (11.1)	0 (0.0)	3 (9.4)	0.471
	R	14 (51.9)	4 (80.0)	18 (56.3)
	S	10 (37.0)	1 (20.0)	11 (34.4)
Rifampicin	R	0 (0.0)	5 (100.0)	5 (15.6)	0.001
	S	27 (100.0)	0 (0.0)	27 (84.4)
Vancomycin	R	10 (37.0)	9 (100.0)	20 (54.1)	0.003
	S	17 (63.0)	0 (0.0)	17 (45.9)
Penicillin G	R	24 (88.9)	—	24 (88.9)	____
	S	3 (11.1)	—	3 (11.1)